News
Step into the World of QT BIO
21
2024-11
Announcement of Change in Company's English Name
The original company name, “Jiangsu Qitian Gene Biotechnology Co., Ltd.” is nowofficially changed to “QT Biotech Co., Ltd.”, with the abbreviation “QT BIO”. Thetransition period for this name change will commence on December 1, 2024, andconclude on December 31, 2024, During this period, we will gradually carry out thename change process, including but not limited to company logos, promotionalmaterials and contract documents.
29
2026-01
Respiratory syncytial virus (RSV) is the leading pathogen causing lower respiratory tract infections (such as pneumonia and bronchitis) in infants and young children worldwide, with no specific vaccines or antiviral drugs currently available.
15
2026-01
With the growing demand for precision medicine, nucleic acid detection technology continues to evolve. Based on technical principles and application scenarios, this article systematically analyzes the core differences between PCR and RAA, with a focus on the innovative value of RAA technology.
29
2025-12
Avian influenza virus (AIV) poses a serious threat to the global poultry industry and public health, especially the highly pathogenic H5 subtype (H5-AIV). Between 2021 and 2022, the number of poultry deaths due to avian influenza exceeded 138 million, highlighting the urgent need to develop rapid detection technologies. Based on RT-RAA technology, this study developed two novel detection methods: RF-RT-RAA and RT-RAA-LFD, which can achieve rapid detection of H5-AIV within 15-30 minutes.
15
2025-12
Dengue fever is a major global public health threat, particularly in Bangladesh, where the epidemic has become increasingly severe in recent years.
20
2025-11
According to a report from the Regional Office for the Americas of the World Health Organization, Brazil reported 294 new suspected cases of Zika virus disease between October 19 and November 8, 2025.
21
2024
/
11
29
2026
/
01
15
2026
/
01
29
2025
/
12
20
2025
/
11